Evidence map›Paper›PMID 41182812›Full record

ArticleTissue engineering. Part A2026

Evaluating Seeding Density Effects on Cardiac Organoid Health and Functionality for Toxicity Studies.

Anirudha Harihara, Khashayar Moshksayan, Nima Momtahan, Adela Ben-Yakar, Janet Zoldan

Abstract read
In one paragraph

Article in Tissue engineering. Part A, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Human cardiovascular organoids: Biomedical applications and ethical challenges.American heart journal plus : cardiology research and practice · 2026
    Review
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Anirudha HariharaDepartment of Mechanical Engineering, The University of Texas at Austin, Austin, Texas, USA.
Khashayar MoshksayanDepartment of Mechanical Engineering, The University of Texas at Austin, Austin, Texas, USA.
Nima MomtahanDepartment of Biomedical Engineering, The University of Texas at Austin, Austin, Texas, USA.
Adela Ben-YakarDepartment of Mechanical Engineering, The University of Texas at Austin, Austin, Texas, USA.
Janet ZoldanDepartment of Biomedical Engineering, The University of Texas at Austin, Austin, Texas, USA.

Funding

Three-dimensional fluorescence imaging flow cytometry at up to million frames per secondR01GM148906 · NIGMS · UNIVERSITY OF TEXAS AT AUSTIN · PI ADELA BEN-YAKAR · 2023 to 2026
$1.6M
NIGMS NIH HHS R01 GM148906
6 · The paper itself

Abstract

Development of relevant human induced pluripotent stem cell-derived cardiac organoids is essential to recapitulate myocardium physiology and functionality for the assessment of drug-induced toxicity evaluations. However, the optimal conditions for culturing self-aggregating multicellular cardiac organoids are not well-elucidated, particularly the impact of noncardiomyocytes. In this study, we generated cardiac organoids at varying seeding densities to formulate organoids that meet or exceed the biological diffusion limit. We assessed their morphology, gene expression profiles, beating functionality, viability, and mitochondrial activity over time. Our results show that organoid sizes stabilize by 7 days of culture, regardless of seeding density. However, organoids seeded with 20,000 cells retained a more optimal cardiac signature that promotes cardiac maturity and minimizes fibrotic tendencies, especially when cultured for longer than 7 days. While all organoid populations maintained their beating functionalities, those seeded with 80,000 cells exhibited greater cell shedding and increased apoptosis at long-term culture. In contrast, minimal apoptosis was observed in organoids seeded with 20,000 cells after 7 days. Mitochondrial staining further revealed that organoids seeded with 20,000 cells consistently demonstrated higher metabolic activity. Taken together, organoids seeded with 20,000 cells and cultured for 7 days yielded the healthiest morphology, transcriptional signature, and viability while maintaining robust beating kinetics. Importantly, the organoid model identified in this study demonstrated a selectivity index (SI) that is over an order of magnitude larger than that of two-dimensional cultures, showing improved sensitivity to clinically relevant doxorubicin-induced cardiotoxicity, enabling more accurate dose-response evaluations that better reflect therapeutic conditions.

Indexed as

Induced Pluripotent Stem CellsMyocardiumOrganoidsToxicity TestsApoptosisCell SurvivalHumansMyocytes, Cardiaccardiac organoidscardiomyocyte–fibroblast interactioncardiotoxicityhuman induced pluripotent stem cellsmaturation

Identifiers

PMID41182812
PMCPMC13024569

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.